Acquisition
Nov 2023Viome acquired Naring Health, including DiscernDX and Foodome, to expand personalized nutrition and longevity offerings.
SourceCompany research
Public company, workplace, funding, and market signals
Updated Aug 16, 2026
Overview
Viome is a Bellevue-based personalized health and diagnostics company that analyzes microbial and human gene expression (mRNA) to provide health insights, diet recommendations, and customized supplements; it is expanding into diagnostics for early disease detection.
Primary product
At-home microbiome / mRNA-based health tests with personalized nutrition recommendations and supplements
Founded
2016
Headquarters
Bellevue, Washington, United States
Team size
50-60
Industry
Wellness and Fitness Services
Sub-industry
Personalized health diagnostics / microbiome testing / precision nutrition
Offices
205 108th Ave NE, Bellevue, Washington 98004, United States
10800 NE 8th St, Suite 910, Bellevue, Washington 98004, United States
Bothell, Washington, United States
New York, New York, United States
Business model
direct-to-consumer
retail distribution
B2B / clinical diagnostics
Funding
Stage
Series D (internal / announced in 2024)
Total raised
$301M
Latest round
Series D · Sep 2024
Latest amount
$25M
Sep 2024 · Existing / internal backers including Khosla Ventures, Bold Capital, WRG Ventures, Marc Benioff
Aug 2023 · Khosla Ventures and Bold Capital
Jan 2021
Jan 2019
Aug 2017
People & investors
Leadership
Founder & CEO
Co-founder, Chief Science Officer, and Head of Clinical Research
Former President
President, Consumer
Chief Marketing Officer
Head of Women's Health
Board Member
Kal Raman
Chief Operating Officer
Founders
Founding CTO & Head of Discovery AI
Founder & President (historical)
Co-founder, Founding CSO & Head of Clinical Research
Work & culture
Publicly available signals suggest a science-driven, mission-oriented company emphasizing personalized health, collaboration, and rapid innovation; I did not find a reliable public benefits page or explicit remote/hybrid policy in primary sources.
Compensation
Public signals include reported salary ranges for roles such as Senior Software Engineer, Data Scientist, and Research Associate in third-party company datasets; no formal compensation philosophy or transparent company-wide salary bands were found on primary sources.
Product & market
Pricing
Direct-to-consumer test kits, subscription-like personalized nutrition/supplement offerings, and retail/partner distribution agreements; diagnostics expansion may add clinical revenue streams.
Differentiators
- —Uses mRNA / gene-expression analysis rather than only DNA or microbiome taxonomies
- —Exclusive licensing from Los Alamos National Lab cited in company materials
- —Combines testing with personalized food and supplement recommendations
- —Expanded into oral health and diagnostic tests
- —Large proprietary gene-expression database and AI-driven analysis
- —Retail distribution through CVS and other partners
Technology
Java
Scala
Spring Boot
Python
SQL
GitHub
Jira
Confluence
Slack
Workday
Salesforce
Google Analytics
Amplitude
Figma
Shopify
Okta
Klaviyo
FullStory
LinkedIn
Facebook Ads/Meta
Customers
Consumers buying at-home health tests
Patients / providers in diagnostic and clinical settings
Retail partners such as CVS (distribution)
Competitors
Zoe
Thryve
uBiome
DayTwo
InsideTracker
Function Health
Everlywell
Ome
Scale & contact
Estimated revenue
$100M-$150M
Estimated monthly visits
206.6K
Traffic estimate as of Jun 2026
Signals & risks
Other
Sep 2024Viome announced a $25M internal Series D and added Kal Raman as COO while launching a diagnostics division; the round was described as internal / existing backers rather than broad market fundraising.
SourceLatest news
Scripps Research · Jul 2025
Viome and Scripps Research announced a 1,000-patient study to validate an at-home RNA test for precancerous colon polyps, extending Viome’s diagnostics work beyond oral and throat cancer.
PR Newswire · Jul 2025
Viome announced a collaboration with Microsoft Azure to scale its RNA and AI platform for preventive and personalized healthcare.
PR Newswire · Apr 2025
Viome launched its most comprehensive consumer test, emphasizing dynamic biology, AI-driven recommendations, and broader health scoring.
PR Newswire · Sep 2024
Announced a $25M internal Series D, named Kal Raman COO, and said capital would support a new diagnostics division including IBS/IBD-related tests.
GeekWire · Sep 2024
Viome raised a $25 million Series D and hired Kal Raman as COO to help expand its diagnostics division.
Jobs and careers at Viome
2 jobs at Viome
Accountant
On-site
Bellevue, WA
3w ago
On-site
Full-time
Senior Product Manager, Consumer
Remote
Bellevue, WA
4mo ago
Remote
Full-time